Gartner, Inc. Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture
Gartner, Inc. (IT) reported Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture of $6.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity
us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation · last filed 2026-08-04
- Gartner, Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2026-06-30 was $6.17M, a 20.45% decline year-over-year.
- Gartner, Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2026-03-31 was $8.69M, a 11.03% decline year-over-year.
- Gartner, Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-09-30 was $7.76M, a 22.12% increase year-over-year.
- Gartner, Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-06-30 was $7.76M, a 20.76% increase year-over-year.
- Gartner, Inc. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2025 was $32.56M, a 15.13% increase from fiscal 2024.
- Gartner, Inc. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2024 was $28.28M, a 12.18% increase from fiscal 2023.
- Gartner, Inc. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2023 was $25.21M, a 13.08% increase from fiscal 2022.
- Gartner, Inc. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2022 was $22.30M, a 22.17% increase from fiscal 2021.
| Period end | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 6 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 9 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.17M 10-Q · filed 2026-08-04 | $14.86M derived: sum of 2 quarters · filed 2026-08-04 | ||
| 2026-03-31 | $8.69M 10-Q · filed 2026-08-04 | |||
| 2025-12-31 | $32.56M 10-K · filed 2026-02-12 | |||
| 2025-09-30 | $7.76M 10-Q · filed 2025-11-04 | $15.52M derived: sum of 2 quarters · filed 2026-08-04 | $25.29M derived: sum of 3 quarters · filed 2026-08-04 | |
| 2025-06-30 | $7.76M 10-Q · filed 2026-08-04 | $17.53M derived: sum of 2 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $9.77M 10-Q · filed 2026-08-04 | |||
| 2024-12-31 | $28.28M 10-K · filed 2026-02-12 | |||
| 2024-09-30 | $6.36M 10-Q · filed 2025-11-04 | $12.78M derived: sum of 2 quarters · filed 2025-11-04 | $20.85M derived: sum of 3 quarters · filed 2025-11-04 | |
| 2024-06-30 | $6.43M 10-Q · filed 2025-11-04 | $14.50M derived: sum of 2 quarters · filed 2025-11-04 | ||
| 2024-03-31 | $8.07M 10-Q · filed 2025-11-04 | |||
| 2023-12-31 | $25.21M 10-K · filed 2026-02-12 | |||
| 2023-09-30 | $5.89M 10-Q · filed 2024-11-05 | $11.79M derived: sum of 2 quarters · filed 2024-11-05 | $19.17M derived: sum of 3 quarters · filed 2024-11-05 | |
| 2023-06-30 | $5.90M 10-Q · filed 2024-11-05 | $13.28M derived: sum of 2 quarters · filed 2024-11-05 | ||
| 2023-03-31 | $7.38M 10-Q · filed 2024-11-05 | |||
| 2022-12-31 | $22.30M 10-K · filed 2025-02-13 | |||
| 2022-09-30 | $4.99M 10-Q · filed 2023-11-03 | $10.05M derived: sum of 2 quarters · filed 2023-11-03 | $17.02M derived: sum of 3 quarters · filed 2023-11-03 | |
| 2022-06-30 | $5.06M 10-Q · filed 2023-11-03 | $12.03M derived: sum of 2 quarters · filed 2023-11-03 | ||
| 2022-03-31 | $6.96M 10-Q · filed 2023-11-03 | |||
| 2021-12-31 | $18.25M 10-K · filed 2024-02-15 | |||
| 2021-09-30 | $4.13M 10-Q · filed 2022-11-01 | $8.21M derived: sum of 2 quarters · filed 2022-11-01 | $13.59M derived: sum of 3 quarters · filed 2022-11-01 | |
| 2021-06-30 | $4.08M 10-Q · filed 2022-11-01 | $9.46M derived: sum of 2 quarters · filed 2022-11-01 | ||
| 2021-03-31 | $5.38M 10-Q · filed 2022-11-01 | |||
| 2020-12-31 | $18.14M 10-K · filed 2023-02-16 | |||
| 2020-09-30 | $4.11M 10-Q · filed 2021-11-02 | $8.20M derived: sum of 2 quarters · filed 2021-11-02 | $13.86M derived: sum of 3 quarters · filed 2021-11-02 | $18.26M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $4.09M 10-Q · filed 2021-11-02 | $9.74M derived: sum of 2 quarters · filed 2021-11-02 | $14.14M derived: sum of 3 quarters · filed 2022-02-23 | $18.32M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $5.65M 10-Q · filed 2021-11-02 | $10.05M derived: sum of 2 quarters · filed 2022-02-23 | $14.23M derived: sum of 3 quarters · filed 2022-02-23 | $18.24M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $8.57M derived: sum of 2 quarters · filed 2022-02-23 | $12.59M derived: sum of 3 quarters · filed 2022-02-23 | $17.65M 10-K · filed 2022-02-23 |
| 2019-09-30 | $4.17M 10-Q · filed 2020-11-03 | $8.19M derived: sum of 2 quarters · filed 2020-11-03 | $13.25M 10-Q · filed 2019-10-31 | $16.90M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $4.01M 10-Q · filed 2020-11-03 | $9.08M 10-Q · filed 2019-07-30 | $12.73M derived: sum of 3 quarters · filed 2021-02-24 | $16.19M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $5.06M 10-Q · filed 2020-11-03 | $8.71M derived: sum of 2 quarters · filed 2021-02-24 | $12.18M derived: sum of 3 quarters · filed 2021-02-24 | $11.10M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $7.12M derived: sum of 2 quarters · filed 2021-02-24 | $6.04M derived: sum of 3 quarters · filed 2021-02-24 | $10.18M 10-K · filed 2021-02-24 |
| 2018-09-30 | $3.46M 10-Q · filed 2019-10-31 | $2.39M derived: sum of 2 quarters · filed 2019-10-31 | $6.53M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | -$1.08M 10-Q · filed 2019-07-30 | $3.07M 10-Q · filed 2019-07-30 | ||
| 2018-03-31 | $4.14M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |